A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome

NCT01041846 · clinicaltrials.gov ↗

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: No intervention

Sponsor

Janssen Korea, Ltd., Korea